Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents

Includes bibliographical references.

Saved in:
Bibliographic Details
Main Author: Biwi, James Tapiwa
Other Authors: Hunter, Roger
Format: Thesis
Language:English
Published: Department of Chemistry 2015
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867614479267659776
access_status_str Open Access
author Biwi, James Tapiwa
author2 Hunter, Roger
author_browse Biwi, James Tapiwa
Hunter, Roger
author_facet Hunter, Roger
Biwi, James Tapiwa
author_sort Biwi, James Tapiwa
collection Thesis
description Includes bibliographical references.
format Thesis
id oai:open.uct.ac.za:11427/12826
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:52:41.826Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2015
publishDateRange 2015
publishDateSort 2015
publisher Department of Chemistry
publisherStr Department of Chemistry
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/12826 A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents Biwi, James Tapiwa Hunter, Roger Kaschula, Catherine Hart Chemistry Includes bibliographical references. Ajoene (( E-/Z )-4,5,9-trithiadodeca-1,6,11-triene-9-oxide), a constituent of garlic is known to possess in vitro and in vivo anticancer activity based on the presence of a vinyl disulfide as its pharmacophore. This thesis reports on the synthesis of dihydroajoenes, a novel set of ajoene analogues, containing a saturated double bond, in which the intention was to study the influence of removing the double bond on biological activity and metabolic stability, since ajoenes are unstable in blood. A divergent synthetic route to 6 new dihydroajoene analogues has been developed in which a phenolic hydroxyl group at the disulfide end served as a platform for modulating aqueous solubility. The dihydroajoene analogues synthesized retained good in vitro anti-proliferation activity against a WHCO1 oesophageal cancer cell line, with the phenol derivative showing the greatest activity, with an IC 50 of 4.1 μM as about 7-times more active than the parent ajoene. In addition the dihydroajoenes were found to be significantly more stable in the red blood cell fraction of mouse blood, when compared with ajoene analogues retaining the double bond. This opens up the possibility of exploring them as anti-cancer agents in an in vivo setting. This thesis also describes a preliminary study towards the synthesis of an ajoene-drug (fludarabine) conjugate for chemosensitization studies, in which an advanced synthetic intermediate was secured. 2015-05-18T14:24:49Z 2015-05-18T14:24:49Z 2014 Master Thesis Masters MSc http://hdl.handle.net/11427/12826 eng application/pdf Department of Chemistry Faculty of Science University of Cape Town
spellingShingle Chemistry
Biwi, James Tapiwa
A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents
thesis_degree_str Master's
title A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents
title_full A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents
title_fullStr A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents
title_full_unstemmed A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents
title_short A Structure-Activity Relationship Study of Dihydroajoenes as Anti-Cancer Agents
title_sort structure activity relationship study of dihydroajoenes as anti cancer agents
topic Chemistry
url http://hdl.handle.net/11427/12826
work_keys_str_mv AT biwijamestapiwa astructureactivityrelationshipstudyofdihydroajoenesasanticanceragents
AT biwijamestapiwa structureactivityrelationshipstudyofdihydroajoenesasanticanceragents